From ongoing hearings before Congress, to recent actions before the World Health Organization, the problem of high drug prices and its impact on affordable health care has reached the boiling point internationally.At first glance, the “easiest” solution would be some form of price control, achieved through direct price control regulations, caps on patient costs under health-care plans or through low-cost compulsory licenses, such as march-in rights under the Bayh-Dole Act, 35 U.S.C. Section 203.Yet, as I have …